DE SARRO, GIOVAMBATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 11.972
AS - Asia 7.866
EU - Europa 4.209
SA - Sud America 1.909
AF - Africa 205
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 26
AN - Antartide 2
Totale 26.283
Nazione #
US - Stati Uniti d'America 11.326
SG - Singapore 3.413
CN - Cina 1.801
IT - Italia 1.612
BR - Brasile 1.501
IN - India 935
VN - Vietnam 813
GB - Regno Unito 609
DE - Germania 592
CA - Canada 509
SE - Svezia 435
FI - Finlandia 283
HK - Hong Kong 189
AR - Argentina 146
ID - Indonesia 105
NL - Olanda 99
FR - Francia 98
MX - Messico 97
AU - Australia 84
JP - Giappone 80
RU - Federazione Russa 77
EC - Ecuador 75
BD - Bangladesh 71
ZA - Sudafrica 71
CO - Colombia 62
AE - Emirati Arabi Uniti 61
PK - Pakistan 58
ES - Italia 55
TR - Turchia 54
CL - Cile 49
RO - Romania 49
UA - Ucraina 47
EG - Egitto 41
IQ - Iraq 40
PL - Polonia 40
IR - Iran 31
KR - Corea 31
CZ - Repubblica Ceca 25
PY - Paraguay 25
SA - Arabia Saudita 24
CH - Svizzera 22
AT - Austria 21
MA - Marocco 20
IL - Israele 19
UZ - Uzbekistan 19
VE - Venezuela 19
MY - Malesia 18
PE - Perù 18
EU - Europa 17
GR - Grecia 17
IE - Irlanda 17
PH - Filippine 16
TW - Taiwan 16
EE - Estonia 14
PT - Portogallo 13
NO - Norvegia 12
TN - Tunisia 12
UY - Uruguay 12
DO - Repubblica Dominicana 10
NP - Nepal 10
RS - Serbia 10
LT - Lituania 9
NZ - Nuova Zelanda 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AL - Albania 8
HN - Honduras 8
MD - Moldavia 8
SC - Seychelles 8
KW - Kuwait 7
KZ - Kazakistan 7
MT - Malta 7
AZ - Azerbaigian 6
KE - Kenya 6
NG - Nigeria 6
TH - Thailandia 6
BE - Belgio 5
JO - Giordania 5
UG - Uganda 5
AO - Angola 4
BH - Bahrain 4
GH - Ghana 4
HR - Croazia 4
LK - Sri Lanka 4
SN - Senegal 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
FO - Isole Faroe 3
GT - Guatemala 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AQ - Antartide 2
BB - Barbados 2
BJ - Benin 2
BO - Bolivia 2
CG - Congo 2
Totale 26.230
Città #
Dallas 2.011
Chandler 1.671
Singapore 1.320
Santa Clara 652
Bengaluru 618
Hefei 598
Milan 591
Princeton 532
Lawrence 520
Munich 475
Shenzhen 397
London 390
Chicago 378
Ashburn 361
Ottawa 333
Wilmington 317
Ho Chi Minh City 308
Beijing 194
Des Moines 185
Catanzaro 178
Hong Kong 163
Hanoi 160
São Paulo 156
Helsinki 136
Turku 126
Boardman 125
New York 124
Los Angeles 113
Redwood City 82
Brooklyn 81
The Dalles 74
Tokyo 63
Columbus 57
Norwalk 52
Rio de Janeiro 51
Pune 49
Council Bluffs 47
Shanghai 46
Haiphong 44
Boston 43
Montreal 41
Guangzhou 40
Johannesburg 38
Rome 38
San Francisco 36
Palermo 35
Curitiba 34
Redmond 34
Toronto 32
Chennai 31
Jakarta 31
Amsterdam 29
Atlanta 29
Guayaquil 29
Melbourne 29
Porto Alegre 29
Hải Dương 28
West Jordan 28
Da Nang 27
Mexico City 27
Warsaw 27
Brasília 26
Falls Church 26
Seattle 24
Belo Horizonte 23
Bogotá 23
Campinas 23
Phoenix 23
Buenos Aires 22
Hyderabad 22
Istanbul 22
San Nicola Manfredi 22
Augusta 21
Florence 21
Padova 21
Santiago 21
Stockholm 21
Thái Bình 21
Biên Hòa 20
Naples 20
Messina 19
Olomouc 19
Charlotte 18
Quito 18
Buffalo 17
Delhi 17
Mumbai 17
Tashkent 17
Bari 16
Santa Maria 16
Guarulhos 15
Hanover 15
Santo André 15
Aversa 14
Horia 14
Houston 14
Ribeirão Preto 14
Salvador 14
Ankara 13
Dhaka 13
Totale 15.230
Nome #
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 607
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 503
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 475
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 423
Adherence to therapy and adverse drug reactions: is there a link? 269
Adverse effects of atypical antipsychotics in the elderly: a review 249
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 235
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 174
Neuropharmacology of depression in aging and age-related diseases 163
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 149
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 147
Genetics of reflex seizures and epilepsies in humans and animals 143
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities 142
Conventional and new antidepressant drugs in the elderly 132
A POSSIBLE DRUG-FOOD INTERACTION INDUCED GENERALISED URTICARIA IN A YOUNG WOMAN 130
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 120
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 106
Conventional and atypical antipsychotics in the elderly - A review 104
Transient Receptor Potential Ankyrin 1 (TRPA1) mediates hydrogen sulfide-induced Ca2+ entry and nitric oxide production in human cerebrovascular endothelium. 100
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 100
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 99
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 98
Efficacy and safety of bevacizumab in glioblastomas 96
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 95
Venlafaxine-Propafenone interaction resulting in hallucinations and psychomotor agitation 95
Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats 91
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 90
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 89
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 88
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 87
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 85
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 84
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 83
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 81
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 77
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 76
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment 75
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 74
9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models 73
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 73
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 71
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 71
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 71
Melaena following use of the cholinesterase inhibitor rivastigmine 70
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 70
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 69
Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 69
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 69
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 69
Lithium in late-life mania: a systematic review 69
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 67
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 67
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 67
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 67
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 66
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 66
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 66
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 66
Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. 65
QUINOLONES POTENTIATE CEFAZOLIN-INDUCED SEIZURES IN DBA/2 MICE 64
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 64
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 64
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 64
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 63
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 63
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 63
Asterixis as initial manifestation of cerebellar ischemic stroke 63
Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study 63
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 62
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 62
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 62
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 61
Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice 60
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 60
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman 60
A fatal case of triple whammy in an elderly patient 60
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 60
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy 60
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 59
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 59
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 59
A case of adverse drug reaction induced by dispensing error 59
Adverse drug reactions related to drug administration in hospitalized patients. 59
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 59
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 59
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 59
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 58
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 58
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 58
Methodological issues associated with clinical trials in epilepsy 58
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 57
Data recorded in real life support the safety of nattokinase in patients with vascular diseases 57
Pharmacokinetic considerations about antiseizure medications in the elderly 56
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 55
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 55
A new model of experimental epilepsy: the cefazolin-induced epilepsy. 55
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis 55
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 55
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 55
Analgesic and Anti-Inflammatory Effects of Perampanel in Acute and Chronic Pain Models in Mice: Interaction With the Cannabinergic System 55
Totale 9.912
Categoria #
all - tutte 264.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 264.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021468 0 0 0 0 0 196 61 22 80 76 23 10
2021/20221.557 5 15 23 420 52 40 24 338 197 187 235 21
2022/20234.750 1.096 216 92 447 480 427 35 371 779 331 365 111
2023/20242.885 475 293 590 157 136 545 118 120 44 122 106 179
2024/20257.113 963 346 371 306 477 914 453 294 850 360 670 1.109
2025/20269.154 700 1.704 2.668 2.493 1.583 6 0 0 0 0 0 0
Totale 26.793